Comparing STRATA Skin Sciences (NASDAQ:SSKN) & AtriCure (NASDAQ:ATRC)

AtriCure (NASDAQ:ATRC) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, profitability, dividends, risk and institutional ownership.

Analyst Ratings

This is a breakdown of recent recommendations for AtriCure and STRATA Skin Sciences, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AtriCure 0 1 5 0 2.83
STRATA Skin Sciences 0 0 2 0 3.00

AtriCure presently has a consensus target price of $36.83, indicating a potential upside of 41.67%. STRATA Skin Sciences has a consensus target price of $6.00, indicating a potential upside of 163.16%. Given STRATA Skin Sciences’ stronger consensus rating and higher possible upside, analysts clearly believe STRATA Skin Sciences is more favorable than AtriCure.

Risk and Volatility

AtriCure has a beta of 0.33, indicating that its share price is 67% less volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.58, indicating that its share price is 58% more volatile than the S&P 500.

Profitability

This table compares AtriCure and STRATA Skin Sciences’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AtriCure -9.46% -13.06% -8.91%
STRATA Skin Sciences N/A N/A N/A

Insider and Institutional Ownership

88.9% of AtriCure shares are held by institutional investors. Comparatively, 32.1% of STRATA Skin Sciences shares are held by institutional investors. 8.0% of AtriCure shares are held by insiders. Comparatively, 45.6% of STRATA Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares AtriCure and STRATA Skin Sciences’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
AtriCure $201.63 million 5.00 -$21.14 million ($0.94) -27.66
STRATA Skin Sciences $31.45 million 2.17 -$18.83 million N/A N/A

STRATA Skin Sciences has lower revenue, but higher earnings than AtriCure.

Summary

STRATA Skin Sciences beats AtriCure on 8 of the 12 factors compared between the two stocks.

About AtriCure

AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures; EPi-Sense guided coagulation system used for the coagulation of tissue; and COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy. It also provides multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable users to make longer linear lines of ablation. In addition, the company offers cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias; AtriClip system used to occlude the left atrial appendage by mechanically clamping the appendage; and CryoICE CRYO2 cryoablation system to apply cryo-energy to targeted intercostal peripheral nerves in the ribcage and temporarily relieve pain. Further, it provides Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation; Fusion Magnetic Retriever System that allows access around anatomical structures; and cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.

About STRATA Skin Sciences

STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.

Receive News & Ratings for AtriCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AtriCure and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit